By the end of the experiment (day 40), none of the mice injected with CD109KO cells (0/6) developed any tumors, whereas all mice injected with A431 cells formed tumors (6/6) (Figure 1A–D), indicating that the loss of CD109 eliminated xenograft tumor growth of A431 SCC cells in vivo. The gene discussed is CD109; the disease is neoplasm.